FDA approvals are critical for pharmaceutical companies, often leading to increased investor confidence and potential revenue growth from new treatments. As CASGEVY is directly related to Vertex's core business, this approval is highly relevant and important for the company's future performance. The positive impact on the stock price is likely, assuming no negative market conditions or company-specific issues arise.